Introduction {#s1}
============

Found in remote sub-Saharan areas where health systems are often weak and/or destabilised by armed conflict, human African trypanosomiasis (HAT, or sleeping sickness) is one of the world\'s most neglected tropical diseases (NTDs). It is caused by trypanosome parasites that are transmitted primarily through the bites of infected tsetse flies (*Glossina*). It is nearly always fatal if untreated. HAT caused by *Trypanosoma brucei gambiense* represents more than 90% of global HAT burden and is endemic in small geographic foci in 24 countries of west and central Africa [@pntd.0002003-Simarro1]. Humans are assumed to be the main reservoir of infection in these areas.

In the first stage of disease, when parasites are found in the blood, lymph and organ systems, HAT can be asymptomatic or involve non-specific symptoms. Patients are considered to be in the second stage of disease once there is evidence that parasites have entered the brain and cerebro-spinal fluid (CSF), and it is at this time that characteristic symptoms are more likely to appear, involving mental and physical deterioration progressing to death [@pntd.0002003-Blum1], [@pntd.0002003-Dumas1]. The natural duration of *gambiense* HAT is thought to be almost a year and a half for each stage [@pntd.0002003-Checchi1].

HAT diagnosis is currently not feasible in peripheral primary health care structures as it requires refrigeration, electricity, specific equipment and a high level of technical expertise [@pntd.0002003-Chappuis1], [@pntd.0002003-Checchi2]. Systematic active screening (AS) of at-risk populations using laboratory-equipped mobile teams is used to increase access to treatment and reduce the infectious pool [@pntd.0002003-Simarro1], [@pntd.0002003-Cattand1], [@pntd.0002003-Meda1], [@pntd.0002003-Simarro2], but is considerably more expensive than passive screening (PS) at static facilities. Despite calls for an intensification of control activities coherent with an elimination aim [@pntd.0002003-WHO1], funding for such activities on the ground, especially for AS and in the most endemic countries, has recently become worryingly scarce [@pntd.0002003-Jannin1], [@pntd.0002003-Yun1]. In South Sudan only 445 people were actively screened for infection in 2010 [@pntd.0002003-RuizPostigo1]. In this resource context, it would be useful to develop case-detection and treatment strategies that can be sustainably implemented by national and local control programmes. Furthermore, targeting testing to symptomatic patients, who probably have a higher probability of being HAT cases than the general population, may be more cost-effective and would reduce the risk of drug related adverse events among false positives [@pntd.0002003-Inojosa1].

One option is to involve non-specialist healthcare workers (HCWs) in peripheral, first and second-tier primary healthcare (PHC) facilities in syndromic recognition of suspect cases; these HCWs are a resource that are often over-looked in vertical HAT control programmes [@pntd.0002003-Mwanakasale1], [@pntd.0002003-Bilengue1]. The WHO cautions against the exclusive use of signs and symptoms for HAT diagnosis since these are known to be nonspecific in HAT and their frequency varies widely between individuals and potentially even geographic regions [@pntd.0002003-WHO2]. However, a simple syndromic algorithm, if sufficiently sensitive, could empower HCWs to recognise and refer suspect HAT patients to a specialised PS facility for diagnostic HAT testing, and could therefore be a useful tool to expand case detection. This could also address the problem of extensive under-diagnosis of HAT at PHC level, which has commonly been identified as a barrier to passive case-detection [@pntd.0002003-Hasker1], [@pntd.0002003-Bukachi1], [@pntd.0002003-Odiit1], [@pntd.0002003-Kovacic1]. A predictable drawback of such algorithms, however, is their low positive predictive value (PPV): HAT prevalence is typically low (\<1--2% in endemic area populations of the most HAT-affected countries; 2.6%--10.8% in treatment-seeking populations presenting for PS [@pntd.0002003-Checchi2]), meaning very high specificity is required to avoid massive over referral. This is difficult to achieve with high sensitivity.

Two studies [@pntd.0002003-Jannin2], [@pntd.0002003-Boatin1] have investigated the potential for HCWs to recognize and refer potential cases of HAT based on presenting symptoms. Boatin et al. (1986) identified a diagnostic scoring algorithm estimated to be 88% sensitive and 82% specific based on a comparison of mostly second stage, passively-detected *rhodesiense* HAT cases (which feature a different clinical profile and evolution than in *gambiense*) and both symptomatic and non-symptomatic controls in Zambia [@pntd.0002003-Boatin1]. Jannin et al. (1993) performed a similar evaluation for *gambiense* HAT populations presenting for AS in the Republic of Congo (RC) and identified an algorithm that was 80% sensitive with a 20% PPV to detect parasitologically-confirmed cases [@pntd.0002003-Jannin2].

A third study [@pntd.0002003-Pepin1] describes an algorithm instituted in peripheral facilities in Democratic Republic of Congo (DRC) to determine the need for laboratory screening, but presents no information on its accuracy. An additional four studies have investigated the use of signs and symptoms for classifying disease stage and/or predicting a fatal prognosis among patients already confirmed as *gambiense* HAT cases; none identified a scoring system sufficiently specific to replace CSF white blood cell counting as a guide to therapeutic decision-making ([@pntd.0002003-Bertrand1], [@pntd.0002003-Edan1], [@pntd.0002003-Antoine1] and secondary analysis of data presented in [@pntd.0002003-Boa1] by [@pntd.0002003-Kegels1]).

We therefore evaluated the predictive value of these and new algorithms in a symptomatic, PS service-using population in the Nimule HAT focus of South Sudan to explore whether any would be appropriate for application in treatment-seeking populations at peripheral health facilities where laboratory testing is unfeasible. The algorithms were designed to be simple to assist HCWs with limited training. The performance of algorithms was also compared to referral decisions made by a panel of clinicians with extensive experience of diagnosing HAT in Africa.

Methods {#s2}
=======

Ethics statement {#s2a}
----------------

This study was approved by the London School of Hygiene & Tropical Medicine\'s ethical review committee and the Ministry of Health, Government (now Republic) of South Sudan. All participants provided verbal informed consent. Verbal consent was approved for use since most patients presenting to the service were not literate; receipt of consent was documented by laboratory staff on data collection forms.

Study setting {#s2b}
-------------

HAT testing and treatment services in the Nimule focus of Magwi County, Eastern Equatoria State are available at a single site, Nimule Hospital, supported by the non-governmental organisation, Merlin (Medical Emergency Relief International) [@pntd.0002003-RuizPostigo1]. Services in this historic focus were re-introduced at the end of the Sudanese civil war, in 2005. Transmission is thought to have increased in recent years due to population movements of IDPs and returnees from neighbouring endemic areas. Small-scale AS surveys conducted in 2005, 2006 and 2008 revealed an estimated HAT prevalence of around 1% with the highest prevalence in any village estimated at 5.8% (Merlin programme data, unpublished).

Community health workers who have received nine months of formal clinical education are the most common cadre (46%) of staff involved in patient diagnosis and management in formal health facilities outside the hospital in the county, followed by staff with no formal clinical education (39%, mainly nursing assistants trained on the job), while only 15% are nurses and clinical officers [@pntd.0002003-Palmer1].

Collection of patient symptom data {#s2c}
----------------------------------

Data on a list of 32 signs, symptoms and epidemiological criteria (henceforth collectively referred to as 'symptoms') were systematically collected from all patients tested for HAT at Nimule hospital over a seven month period from October 2009 to April 2010 (see [Table 1](#pntd-0002003-t001){ref-type="table"}). The list of symptoms included those used in other attempts to create HAT referral algorithms, clinical variables routinely collected at initiation of HAT treatment in the hospital and factors identified as important in local understandings of HAT from previous qualitative work in the study site [@pntd.0002003-Palmer1]. Cases were defined as (i) positive microscopy on lymph fluid directly or on blood using capillary tube centrifugation (Woo test) or (ii) positive CATT on diluted blood serum at dilution 1∶16. Patients positive at dilution 1∶8 were considered serological suspects and followed-up after 3 months. During the study period, first line treatment was pentamidine for stage 1 and eflornithine for stage 2 cases.

10.1371/journal.pntd.0002003.t001

###### Presenting symptom data collected and used in algorithm construction.

![](pntd.0002003.t001){#pntd-0002003-t001-1}

  Individual symptom                             Method of ascertainment   Representation in algorithms after item reduction
  --------------------------------------------- ------------------------- ---------------------------------------------------
  Headache ≥1 week                                   Patient report                            Retained
  Back, neck or joint pain                           Patient report                           Body pains
  Muscle pain                                        Patient report                           Body pains
  Fever ≥1 week                                      Patient report                            Retained
  Itchy skin                                         Patient report                            Retained
  Swollen face, legs or arms                         Patient report                             Oedema
  Weight loss                                        Patient report                            Retained
  Generally poor state of health                       Observation                             Discarded
  Decrease in appetite                               Patient report                        Appetite changes
  Increase in appetite                               Patient report                        Appetite changes
  Impotence                                          Patient report                            Discarded
  No menstruation                                    Patient report                            Discarded
  Enlarged lymph nodes                                 Examination                        Cervical adenopathy
  Insomnia                                           Patient report                      Sleep pattern changes
  Daytime sleeping                                   Patient report                      Sleep pattern changes
  Confusion or forgetfulness                         Patient report                       Abnormal behaviour
  Aggressiveness                                     Patient report                       Abnormal behaviour
  Inactivity                                         Patient report                       Abnormal behaviour
  Hallucinations                                     Patient report                       Abnormal behaviour
  Convulsions                                        Patient report                      Neurological problems
  Difficult speaking                                   Observation                       Neurological problems
  Difficulty walking                                   Observation                       Neurological problems
  Patient unsteady                                     Observation                       Neurological problems
  Jerking movements                                    Observation                       Neurological problems
  Tremor in hands or lips                              Observation                       Neurological problems
  Partial paralysis                                  Patient report                      Neurological problems
  Painful tibia/shin                                   Examination                       Neurological problems
  Treated for malaria/typhoid in last 2 weeks        Patient report             Recent malaria and/or typhoid treatment
  Works/lives with cows                              Patient report              Patient lives or works with livestock
  Works/lives with goats                             Patient report              Patient lives or works with livestock
  Works/lives with sheep                             Patient report              Patient lives or works with livestock
  Works/lives with pigs                              Patient report              Patient lives or works with livestock

All patient data were collected by laboratory staff (technicians and assistants without formal clinical training) before HAT test results were known. Lab staffs were trained to interview patients and recognise symptoms by the HAT programme manager (ES) and study coordinator (JP) before data collection. Interviews were private and patients could be tested without volunteering symptom information. Symptomatic, HAT-negative patients were advised to visit the hospital outpatient department for further management. Patients were only included in the analysis if they presented with at least one of the symptoms on the list and if complete lab test outcome data were available. Both naive and previously-treated patients were included.

Estimation of algorithm performance {#s2d}
-----------------------------------

The 32 individual candidate symptoms were reduced to a more computationally and practically manageable set of 13 as follows. Odds ratios (ORs) were calculated for individual symptoms and for groups of similar symptoms (e.g., 'sleep pattern changes' encompassing 'daytime sleeping' and 'insomnia'). Symptoms that were significantly associated with being a case or non-case only in individual analysis were not grouped with others. Symptoms that were infrequent in the data and/or showed no statistically significant association with case status were discarded ([Table 1](#pntd-0002003-t001){ref-type="table"} and [Table 2](#pntd-0002003-t002){ref-type="table"}). R software, version 2.12 [@pntd.0002003-R1], was used to create all permutations of 4, 3, 2 and 1-symptom algorithms possible from the 13 symptoms shortlisted. Pragmatically, we considered that any algorithm consisting of more than four symptoms would be inappropriate for peripheral health facilities staffed by HCWs with minimal training. Algorithms were interpreted as indicating referral for patients presenting with any (as opposed to all) of the symptoms.

10.1371/journal.pntd.0002003.t002

###### Crude associations between the 13 symptoms used in algorithm construction and a positive HAT test.
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  Symptom                                                   Cases (%) n = 27   Non-cases (%) n = 435   OR     95% CI     p-value
  -------------------------------------------------------- ------------------ ----------------------- ----- ----------- ---------
  Body pains                                                      85.2                 83.5            1.3   0.4--4.5     0.650
  Sleep pattern changes                                           66.7                 54.9            1.6   0.7--3.7     0.238
  Headache ≥1 week                                                55.6                 59.3            0.9   0.4--1.9     0.700
  Abnormal behaviour[\*](#nt101){ref-type="table-fn"}             48.2                 26.9            2.5   1.1--5.6     0.021
  Fever ≥1 week                                                   44.4                 32.6            1.7   0.8--3.6     0.211
  Itchy skin[\*](#nt101){ref-type="table-fn"}                     29.6                  9.7            3.9   1.6--9.7     0.002
  Appetite changes                                                22.2                 14.7            1.7   0.6--4.3     0.295
  Neurological problems[\*](#nt101){ref-type="table-fn"}          22.2                  4.8            5.6   2.5--12.4   \<0.001
  Oedema                                                          14.8                  5.3            3.1   1.0--9.8     0.051
  Recent malaria or typhoid treatment                             14.8                 17.5            0.8   0.3--2.4     0.724
  Weight loss[\*](#nt101){ref-type="table-fn"}                    11.1                  1.8            6.7   1.6--27.2    0.007
  Patient lives/works with livestock                              11.1                 10.3            1.1   0.3--3.7     0.899
  Cervical adenopathy                                             3.7                   3.0            1.2   0.2--9.9     0.834

Significantly associated with being identified as a case, at p\<0.05. Kerendel\'s sign (painful tibia) was present in 33.3% of cases and independently significantly associated with a positive test outcome (individual OR 5.9, p-value \<0.001) but was combined with other more rare symptoms into the larger category 'neurological problems'. There were no significant differences in demographic characteristics (age, sex, residency status, location) between cases and non-cases (data not shown). OR: Odds ratio. CI: Confidence interval.

Each algorithm was then tested against the patient data to compute sensitivity, specificity, PPV and NPV of each, assuming results of lab testing to be a gold standard diagnosis of HAT. The Boatin et al. (1986) and Pepin et al. (1989) algorithms were also tested on the data, as well as three algorithms from the Jannin et al. (1993) study: the best performing algorithm for detecting all HAT patients, including those diagnosed on serology grounds alone ('Jannin-all' algorithm) and the two best-performing algorithms for detecting parasitologically confirmed cases, which in the original study setting yielded a sensitivity of 84% with a PPV of 9% ('Jannin-para2' algorithm) and 80% sensitivity, 20% PPV ('Jannin-para3' algorithm). Minor deviations from the algorithms as originally published were made due to the way data were collected in this study ([Table 3](#pntd-0002003-t003){ref-type="table"}).

10.1371/journal.pntd.0002003.t003

###### Modified algorithms from other HAT studies tested using Nimule Hospital data.
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                                                              Algorithm                             
  ---------------------------------------------------------- ----------- -------- -------- -------- --------
  Headache ≥1 week                                                2         1        1        1        1
  Fever ≥1 week                                                   2         \-       1       1.5      1.5
  Fever unresponsive to anti-malarial                            \-         1        \-       \-       \-
  Oedema                                                          2         \-       3        3        3
  Itching                                                         2         1        \-       1        1
  General body pain                                               1         1        \-       \-       \-
  Weight loss                                                    \-         1        \-       \-       \-
  Sleep problems                                                  1         1       0.5       \-       \-
  Neurological problems                                          \-         \-      0.5       \-       \-
  Cervical adenopathy                                            \-         \-      4.5      4.5      4.5
  Livestock in compound                                          \-         \-       1        1        1
  (Family history of HAT)[\*](#nt103){ref-type="table-fn"}       \-         \-       1       1.5      1.5
  **Threshold score for referral**                             **≥4**     **≥1**   **≥1**   **≥2**   **≥3**

Numbers indicate scores attributed to each symptom, if present.

Data on this symptom were not collected in this study.

Comparison with expert clinician performance {#s2e}
--------------------------------------------

Four clinicians with expertise in HAT patient management were asked to review anonymised patient symptom data and, blinded to the test outcome, decide whether they would have referred the patient for HAT testing. These experts (ES, AL, AP, SK) were selected for their substantial experience in direct HAT patient management in *T.b. gambiense*-endemic areas (South Sudan, DRC, RC and Central African Republic). Experts were told only that patients came from an area with about 1% HAT prevalence and were asked to make referral decisions (yes or no responses allowed only) as if they were working in a PHC facility without HAT testing capacity, one day\'s walk from the HAT treatment centre. The only other information provided on patients was sex, age (≤14 years or \>14 years) and whether the patient had ever been treated for HAT. Accuracy indicators were computed as above. Qualitative comments from experts about some of the difficulties they encountered in assigning referral decisions were taken into account when interpreting subsequent analyses.

The extent of agreement among experts\' referral decisions was computed so as to establish the level of consensus about what an appropriate clinical picture for HAT referral might be. Cohen\'s kappa was used to measure inter-rater agreement between pairs of raters and Fleiss\' kappa between multiple raters [@pntd.0002003-Fleiss1]. Cases for which experts unanimously agreed to refer were explored to identify symptoms that were strongly associated with a unanimous decision to refer. So as to account for potential confounding in these associations, a generalised linear model with robust error variances [@pntd.0002003-Zou1] was used to estimate these associations by including all symptoms significant at the 90% confidence level in univariable analysis into a multivariable model, using a forward stepwise procedure. The final model contained all symptoms that remained significantly associated at the 95% level. Age, sex and previous HAT treatment history were considered as potential confounders for referral, and were forced into the model to adjust for their potential effect. All statistical analyses were performed using Stata software, version 11 (StataCorp, Texas 2009).

Results {#s3}
=======

Performance of syndromic algorithms {#s3a}
-----------------------------------

Complete symptom and test outcome data were available for 462/652 (70.9%) patients tested passively for HAT during the 7 month study period. Incomplete symptom data were largely due to a staff shortage in the hospital laboratory over a 10 week period. 27/462 patients were confirmed as cases, of whom 24 (89%) were parasitologically confirmed and 24 (89%) were in stage 2, yielding a prevalence of 5.8% among patients tested.

Out of 14,067 possible candidate algorithms evaluated, more than half showed a sensitivity greater than 95%, but specificity and PPV were uniformly low, and the latter remained \<15% even for algorithms that had a sensitivity as low as 50% (median sensitivity 96.3% (inter-quartile range: 88.9--100.0%), specificity 1.6% (0.2--6.7%), PPV 5.8% (5.7--5.9%) and NPV 94.9% (87.5--100.0%), [Figure 1](#pntd-0002003-g001){ref-type="fig"}). The best-performing algorithms consisted of three core symptoms (sleep problems, neurological problems and weight loss), with or without a history of oedema, cervical adenopathy or proximity to livestock (algorithms 4, 6, 8 and 10 in [Table 4](#pntd-0002003-t004){ref-type="table"}, sensitivity 88.9--92.6%, PPV 8.4--8.7). Algorithm 4 (sleep problems AND/OR neurological problems AND/OR weight loss AND/OR oedema) appeared to offer the highest combination of sensitivity (92.6%) and PPV (8.7%).

![Receiver operating curve diagram of all candidate syndromic algorithms evaluated.\
Each point represents the sensitivity and 1-specificity of a single algorithm. Ideally, the highest performing algorithms would be located in the top left corner of the graph.](pntd.0002003.g001){#pntd-0002003-g001}

10.1371/journal.pntd.0002003.t004

###### Candidate syndromic algorithms with the 10 highest PPVs and sensitivity ≥75%.
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  Algorithm    Sx n   Body pains   Sleep pattern change   Headache ≥1 week   Abnormal behaviour   Fever ≥1 week   Neurological problems   Itchy skin   Appetite changes   Oedema   Malaria/typhoid   Weight loss   Livestock   Cervical adenopathy   Patients referred (%)   Sensitivity (%)   Specificity (%)   PPV (%)   NPV (%)
  ----------- ------ ------------ ---------------------- ------------------ -------------------- --------------- ----------------------- ------------ ------------------ -------- ----------------- ------------- ----------- --------------------- ----------------------- ----------------- ----------------- --------- ---------
  1             4                                                                    Y                  Y                                                                   Y                                                           Y                 248 (53.7)              81.5              48.0           8.9      97.7
  2             4                                                                    Y                                      Y                                 Y                           Y                                                               239 (51.7)              77.8              49.9           8.8      97.3
  3             4                                                                                       Y                   Y                 Y                                                                        Y                                  242 (52.4)              77.8              49.2           8.7      97.3
  4             4                           Y                                                                               Y                                               Y                             Y                                               289 (62.6)              92.6              39.3           8.7      98.8
  5             3                                                                    Y                  Y                                                                   Y                                                                             245 (53.0)              77.8              48.5           8.6      97.2
  6             3                           Y                                                                               Y                                                                             Y                                               281 (60.8)              88.9              40.9           8.5      98.3
  7             4                                                                    Y                  Y                                                                   Y                             Y                                               246 (53.2)              77.8              48.3           8.5      97.2
  8             4                           Y                                                                               Y                                                                             Y            Y                                  295 (63.9)              92.6              37.9           8.5      98.8
  9             4                                                N                                                                            Y                                                                        Y                Y                 249 (53.9)              77.8              47.6           8.4      97.2
  10            4                           Y                                                                               Y                                                                             Y                             Y                 287 (62.1)              88.9              39.5           8.4      98.3

Sx n: The number of symptoms in the algorithm. Y/N: According to the algorithm, the symptom should (Y/yes) or should not (N/no) be present in the patient being referred. When used by HCWs in practice, algorithms containing more than one symptom should be read as indicating referral if patients present with any (as opposed to all) of the symptoms listed, i.e., symptom A and/or symptom B and/or symptom C and/or symptom D. Patients referred = the number of patients out of 462 who matched the algorithm being tested.

The number of presenting HAT symptoms did not appear to predict infection well: algorithms based on the number of presenting HAT symptoms (regardless of which) fared worse at predicting HAT infection than the best-performing algorithm identified above (e.g. the presence of ≥4/13 symptoms, regardless of which, yielded a sensitivity 63% and PPV 8.5; other data not shown).

The Boatin, Pepin and Jannin algorithms also featured low PPV and, in addition, for the Boatin and Jannin algorithms, low sensitivity; the Pepin algorithm featured very high sensitivity but very low specificity ([Table 5](#pntd-0002003-t005){ref-type="table"}).

10.1371/journal.pntd.0002003.t005

###### Performance of previously published syndromic algorithms.
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  Algorithm       Patients referred (%)   Sensitivity %   Specificity %   PPV %   NPV %
  -------------- ----------------------- --------------- --------------- ------- -------
  Boatin               244 (52.8)             70.4            48.3         7.8    96.3
  Pepin                455 (98.5)             96.3             1.4         5.7    85.7
  Jannin-all           362 (78.4)             85.2            22.1         6.4    96.0
  Jannin-para2         163 (35.3)             55.6            66.0         9.2    96.0
  Jannin-para3          65 (14.1)             29.6            86.9        12.3    95.2

Performance of expert clinicians {#s3b}
--------------------------------

When referral decisions were compared to test outcome data, expert referrers consistently would have referred more cases than non-cases for screening ([Table 6](#pntd-0002003-t006){ref-type="table"}). However, although 3/4 referrers had high sensitivity, their PPVs were lower than the best-performing algorithm identified in this study, corresponding to a higher proportion of patients referred overall (≥75% of patients, as compared to 60%). 62.2% (255/410) of patients were unanimously referred while only 7.1% of patients in the data would not have been referred by any expert.

10.1371/journal.pntd.0002003.t006

###### Performance of expert referrers.
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                                                      Cases referred (%)   Non-cases referred (%)   Chi^2^ p-value   Total pts referred (%)   Sens %   Spec %   PPV %   NPV %
  -------------------------------------------------- -------------------- ------------------------ ---------------- ------------------------ -------- -------- ------- -------
  **Referrer 1**                                          20 (74.1)              248 (57.0)             0.081              268 (58.0)          74.1     43.0     7.5    96.4
  **Referrer 2**                                          26 (96.3)              356 (81.8)             0.054              382 (82.7)          96.3     18.2     6.8    98.8
  **Referrer 3**                                          26 (96.3)              321 (73.8)             0.009              347 (75.1)          96.3     26.2     7.5    99.1
  **Referrer 4** [\*](#nt105){ref-type="table-fn"}        26 (100.0)             345 (89.8)             0.088              371 (80.3)          96.3     89.0     7.0    100.0

No decision for 52 patients. Pts: patients. Sens: sensitivity. Spec: specificity.

Expert approaches to syndromic HAT referral decisions {#s3c}
-----------------------------------------------------

Good agreement on expert referral decisions, with an overall kappa score of 0.56, suggested that experts broadly agreed on what *should* constitute an 'appropriate' HAT referral, however, agreement on referral of actual cases was in fact quite poor (0.27 for cases, 0.57 for non-cases) ([Table 7](#pntd-0002003-t007){ref-type="table"}) [@pntd.0002003-Kirkwood1]. Multivariable analysis of symptoms associated with unanimous referral provided insight as to what experts considered appropriate conditions for referral. Five symptoms (sleep pattern changes, cervical adenopathy, neurological problems, recent malaria/typhoid treatment and abnormal behaviour) retained significance in the final multivariable model at 95% confidence, after adjustment ([Table 8](#pntd-0002003-t008){ref-type="table"}). The only single-symptom algorithm associated with unanimous referral was 'sleep pattern changes'. A combination of previous HAT treatment history and any HAT symptom led to automatic referral for only one expert referrer. Adults (65.5%) were significantly more likely to be referred than children under 15 years (43.1%) (p-value 0.002). There was generally better agreement about what constituted an appropriate referral between expert referrers and the Boatin algorithm than with the Pepin or Jannin algorithms.

10.1371/journal.pntd.0002003.t007

###### Kappa scores assessing agreement between all pairs of expert referrers and expert referrers with algorithms from other HAT studies.
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               Ref 2   Ref 3   Ref 4   Boatin   Pepin   Jannin-all   Jannin-para2   Jannin-para3
  ----------- ------- ------- ------- -------- ------- ------------ -------------- --------------
  **Ref 1**    0.42    0.53    0.30     0.33    0.03       0.09          0.10           0.10
  **Ref 2**     \-     0.77    0.85     0.38    0.07       0.17          0.19           0.07
  **Ref 3**     \-      \-     0.59     0.31    0.04       0.13          0.12           0.07
  **Ref 4**     \-      \-      \-      0.24    0.03       0.24          0.10           0.03

Ref: Referrer. Kappa scores range from 1 representing complete agreement to −1 representing complete disagreement; a score of 0 represents no more agreement than would be expected due to chance.

10.1371/journal.pntd.0002003.t008

###### Multivariable model of key HAT symptoms associated with unanimous expert referral, adjusted for age, sex and previous HAT treatment history (n = 407).
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  Variable                                                       RR-adjusted    95% CI    p-value
  ------------------------------------------------------------- ------------- ---------- ---------
  **Potential confounding variables**                                                    
  Adult age                                                          1.8       1.4--2.4   \<0.001
  Male sex                                                           1.0       0.9--1.1    0.703
  Patient treated for HAT before                                     0.8       0.5--1.2    0.284
  **HAT-specific symptoms** [\*](#nt107){ref-type="table-fn"}                            
  Sleep pattern change                                               2.9       2.3--3.7   \<0.001
  Cervical adenopathy                                                1.8       1.2--2.5    0.003
  Neurological problems                                              1.4       1.3--1.7   \<0.001
  Malaria/typhoid treatment                                          1.3       1.2--1.5   \<0.001
  Abnormal behaviour                                                 1.2       1.1--1.4    0.001

An additional symptom, body pains, was moderately significant in the final model (p-value 0.051).

Discussion {#s4}
==========

Using algorithms to identify HAT syndromically {#s4a}
----------------------------------------------

This study suggests that, for users of a PS service in this South Sudanese focus, algorithms developed for syndromic diagnosis of HAT in other settings have low sensitivity and poor PPV. Ours is the first study specifically to examine the potential effectiveness of syndromic algorithms in a treatment-seeking population and we present here, a simple four-item syndromic algorithm (sleep problems AND/OR neurological problems AND/OR weight loss AND/OR a history of oedema) which had good sensitivity (92.6%) for detecting HAT in such a context. Under this algorithm, and given the prevalence observed in Nimule among patients presenting for testing, about 9 out of 10 referred patients would be non-cases, corresponding to a relatively low PPV. This PPV may, however, be considered an acceptable harm for both patients and health services given the benefit of detecting what is an almost universally fatal disease. Indeed, such an algorithm may allow peripheral HCWs to supplement existing passive and (intermittent) active case finding, and promote integration and strengthening of HAT services within the overall health system. As with all algorithms derived from a single patient group it will need to be tested in independent populations before being recommended for clinical practice, but we consider it is simple enough to be usable by HCWs with limited training.

Expert opinion on the potential of syndromic detection of HAT appears to be unreconciled in the academic literature. Descriptions of how to recognise a case of HAT syndromically abound in the historic and contemporary HAT literature [@pntd.0002003-Dumas1], [@pntd.0002003-Antoine1], [@pntd.0002003-Apted1], [@pntd.0002003-Giordano1], [@pntd.0002003-Burri1], [@pntd.0002003-Tooth1], [@pntd.0002003-Gelfand1], [@pntd.0002003-Stich1], [@pntd.0002003-Low1], [@pntd.0002003-Lambo1] and the presence of one particular sign, cervical adenopathy, was the most important pre-condition for laboratory testing in AS campaigns over most of the 20th Century. On the other hand, formal guidance discusses the challenge of operationalising existing syndromic detection techniques, preferring instead to advocate widespread use of the more sensitive diagnostic technologies developed and refined over the last three decades to avoid the risk of under-detection of a fatal disease [@pntd.0002003-Chappuis1], [@pntd.0002003-Checchi2], [@pntd.0002003-Corty1]. There has been much less discussion of the risk of under-detection of patients who cannot access these technologies directly when, because of operational realities, use of these technologies is not widespread, and who might otherwise benefit from a syndromically-based referral. Perhaps as a result, there are no guidelines targeted to HCWs working in peripheral facilities to help them identify suspect patients in these instances.

Other authors have accepted an algorithm with high sensitivity but low PPV where diagnostic facilities were easily at hand, as in Pepin et al.\'s (1989) study, which equipped all peripheral health facilities in the district with microscopes; this would however have greatly increased these HCWs\' workload and in the current South Sudan context seems unrealistic. Boatin et al. (1986) cautiously proposed the utility of algorithms with high sensitivity but no PPV data for application in HCW referrals of *rhodesiense* HAT, which occurs sporadically over large areas and thus requires effective passive case detection. Jannin et al. (1993), however, rejected algorithms featuring \<10% PPV (albeit with lower sensitivities) because of the heavy workload implications for HCWs. The burden placed on patients to travel to a central testing facility, most of whom would be found negative, was also considered too great by these authors. However, in our study setting of poorly accessible PS services and nonexistent AS, an algorithm with 10% PPV would avert approximately one death for every ten already treatment-seeking patients who were referred to the testing centre. Our panel of experts also appeared to implicitly accept this high rate of false positives, given that they chose to refer a majority of patients in the case series despite knowing that HAT prevalence was 1% in the study area.

The reduced accuracy in Nimule of syndromic algorithms developed in other settings may be due to the lower proportion of symptomatic patients in those cohorts, as already discussed. It may also, however, be due to cultural and linguistic differences in patient perceptions and descriptions of disease. For this reason, it would be useful to validate the algorithm more rigorously in an independent group of patients, first in Nimule and then, if accuracy is confirmed, elsewhere, to explore its applicability in a range of health service contexts. In a high HIV burden setting, three of the four symptoms in this algorithm (neurological problems, weight loss and oedema) could signal various opportunistic infections associated with AIDS, thus further reducing the algorithm\'s specificity; on the other hand, these patients would also benefit from hospital referral.

Out of the four symptoms, 'sleep problems' was the most frequently reported in cases and thus made the greatest contribution to overall sensitivity; however, excessive sleeping (included in this symptom grouping) was frequently reported by both cases (63.0%) and non-cases (49.4%), suggesting that HCWs may face difficulties reliably evaluating its presence in patients. By contrast, neurological symptoms, weight loss and oedema were more discriminating for infection, and yet were rarely associated with HAT by peripheral HCWs interviewed as part of additional research in Nimule (to be published separately) [@pntd.0002003-Palmer1]. Weight loss and oedema were also not strongly associated with unanimous expert referral after accounting for confounding, suggesting that to experts, too, these may be counter-intuitive referral criteria. Although there appeared to be consensus among them on what should constitute an appropriate referral, there was poor agreement on referral decisions for true cases, suggesting that many of these true cases did not match what could be considered their 'consensus case definition'. Alternatively, it may expose difficulties experts faced in making decisions about these symptoms with limited information due to the study design.

Limitations {#s4b}
-----------

Five main limitations affect interpretation of this study\'s findings. First, patient symptom reporting may have been subject to respondent interview bias, including culturally-specific interpretations of some types of symptoms associated with HAT and other conditions. How patients report HAT symptoms in other areas may affect this algorithm\'s generalisability.

Second, data quality may have been affected by the skill of laboratory personnel responsible for collecting them. This has been recognised as a challenge in other studies of HAT symptomatology [@pntd.0002003-Tshimungu1] and may be particularly problematic for recognition of cervical adenopathy [@pntd.0002003-Blum1], [@pntd.0002003-Jannin2]. It is possible that some HAT symptoms more prevalent in true cases were under-detected and therefore had a lower probability of being selected in the final algorithm. It is debatable whether most referring HCWs in peripheral facilities would possess a higher level of clinical skill than the lab attendants trained in this study; if not, the symptoms in this final algorithm may reflect what is, in fact, most practical, in this context. Outside of a research setting, hospital lab staff would not be expected to be involved in syndromic screening since the more sensitive CATT-WB would be available.

Third, the 'gold standard' we used to identify cases in our analysis was the diagnostic algorithm used in the Merlin HAT programme, which, as any HAT diagnostic algorithm, is dependent on the performance of all tests within it and probably has a true sensitivity of between 85--90% and a PPV of around 90% in PS settings [@pntd.0002003-Checchi2]. Little is known about the symptom profile of false negatives excluded by this diagnostic algorithm so it is difficult to predict what effect, if any, these exclusions would have on the sensitivity of the syndromic algorithms we present here. The Merlin diagnostic algorithm is also probably more sensitive than gold standard diagnostic algorithms used to evaluate the syndromic algorithms presented from older studies, making comparisons less straightforward.

Fourth, our algorithm findings are applicable mainly to detection of stage 2 patients, since so few patients in stage 1 were included in the case series. The sensitivity of our algorithms may be lower in routine peripheral settings if the typical clinical profile of HAT cases presenting there is less or differently symptomatic, with proportionately more patients in stage one seeking care.

Finally, our relatively small sample size of 27 cases limits the precision of our estimates of algorithm sensitivity and PPV. Consideration of their 95% confidence intervals (e.g., 75.7--99.1% for sensitivity and 5.7--12.5% for PPV in Algorithm 4) suggests that they may be considered reasonably accurate but the sample size may affect the precise ranking of algorithms; practitioners could, for example, choose to implement or validate any of the top-performing algorithms identified in this study (algorithms 4, 6, 8 and 10 in [Table 4](#pntd-0002003-t004){ref-type="table"}) according to the feasibility of teaching and using them.

Conclusions {#s4c}
-----------

Current HAT diagnostic algorithms are too complex for use in peripheral health structures, and there is very little guidance available to HCWs working in these areas on when to consider referring suspected patients to a central testing facility based on symptoms. This is especially problematic in a context with low AS coverage like the Nimule focus where most HAT patients in the periphery are not detected, or in outbreak situations where funding and capacity for AS is often initially unavailable.

The simple four-symptom referral algorithm identified in this study has the potential to avert one death through testing and treatment for every ten patients referred and to identify most symptomatic HAT patients, if systematically applied. If our findings can be validated in an independent sample, this algorithm could represent a useful additional tool for control programmes to improve case detection in the periphery and promote integration of HAT services within overall health systems at reasonably low added cost.
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